Skip to main content
SpringerLink
Log in

Behandlung der akuten Symptomverschlimmerung in der Hausarztpraxis

Exazerbation der chronisch obstruktiven Lungenerkrankung

Exacerbation of COPD and pharmacological therapy

  • FB_CME
  • Published:
MMW - Fortschritte der Medizin Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1

mod. nach [2]

Literatur

  1. O'Donell DE. Hyperinflation and exercise intolerance in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2006; 3: 180-4

  2. GOLD. Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonra Disease. 2023 Report. https://goldcopd.org/2023-gold-report-2/

  3. O'Donnell DE, Parker CM. COPD exacerbations 3: Pathophysiology. Thorax 2006; 61: 356-61

  4. Casanova C, Cote C, de Torrres JP et al. Inspiratory-to-toal lung capacity ratio predects mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005; 175: 591-7

  5. Miravitlles M, Soler-Cataluna JJ, Calle M et al. Treatment of COPD by clinical phenotypes: putting old evidence into clinical practice. Eur Respir J 2013; 41: 1252-6

  6. Barrecheguren M, Esquinas C, Miravitlles M. The asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS): opportunities and challenges. Curr Opin Pulm Med 2015; 21: 74-9

  7. Aaron SD, Donaldson GC Whitmore GA et al. Time course and pattern of COPD exacerbation onset. Thorax 2012; 67: 238-43

  8. Suissa S, Dell'Aniello S, Ernst P. Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality. Thorax 2012; 67: 957-63

  9. Müllerova H, Maselli DJ, Locantore N et al. Hospitalized Exacerbations of Chronic Obstructive Pulmonary Disease: Risk Factors and Outcomes in the ECLIPSE Cohort. Chest 2015; 147: 999-1007

  10. Vogelmeier C, Buhl R, Burghuber O et al. Leitlinie zur Diagnostik und Therapie von Patienten mit chronisch obstruktiver Bronchitis und Lungenemphysem (COPD). Pneumologie 2018; 72: 253-308

  11. Søgaard M, Madsen M, Løkke A et al. Incidence and outcomes of patients hospitalized with COPD exacerbation with and without pneumonia. Int J Chron Obstruct Pulmon Dis 2016; 11: 455-65

  12. Shin B, Kim SH, Yong SJ et al. Early readmission and mortality in acute exacerbation of chronic obstructive pulmonary disease with community-acquired pneumonia. Chron Respir Dis 2019; 16: 1479972318809480

  13. Sapey E, Stockley RA. COPD exacerbations. 2: Aetiology. Thorax 2006; 6: 250-8

  14. Sethi S, Murphy TF. Acute exacerbations of chronic bronchitis: new developments concerning microbiology and pathophysiology-impact on approaches to risk stratification and therapy. Infect Dis Clin North Am 2004; 18: 861-82

  15. Sethi S. Pathogenesis and treatment of acute exacerbations of chronic obstructive pulmonary disease. Sem. Respir Crit Care Med 2005; 26: 192-203

  16. Rizkallah J, Man SF, Sin DD. Prevalence of pulmonary embolism in acute exacerbations of COPD: a systematic review and metaanalysis. Chest 2009; 135: 786-93

  17. Leuppi JD, Schuetz P, Bingisser et al. Short-term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial. JAMA 2013; 309: 2223-31

  18. Li L, Zhao N, Ma X etal. Personalized Variable vs Fixed-Dose Systemic Corticosteroid Therapy in Hospitalized Patients With Acute Exacerbation of COPD: A Prospective, Multicenter, Randomized, Open-Label Clinical Trial. Chest 2021; 160: 1660-9

  19. Buhl R, Bals R, Baur X et al. S2k-Leitlinie zur Diagnostik und Therapie von Patienten mit Asthma. Pneumologie 2017; 71: 849-919

  20. Anthonisen NR, Manfreda J, Warren CP et al. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 1987; 106: 196-204

  21. Stockley RA, O'Brien C, Pye A et al. Relationship of sputum color to nature and outpatient management of acute exacerbations of COPD. Chest 2000; 117: 1638-45

  22. Mathioudakis AG, Chatzimavridou-Grigoriadou V, Corlateanu A et al. Procalcitonin to guide antibiotic administration in COPD exacerbations: a meta-analysis. Eur Respir Rev 2017; 26: 160073

  23. Bremmer DN, Moffa MA, Ma K et al. Acute Exacerbations of Chronic Obstructive Pulmonary Disease With a Low Procalcitonin Concentration: Impact of Antibiotic Therapy. Clin Infect Dis 2019; 68: 725

  24. Ewig S, Kolditz M, Pletz M et al. Behandlung von erwachsenen Patienten mit ambulant erworbener Pneumonie. Update 2021. Pneumologie 2021; 75: 665-729

  25. Mohamed Amine M, Selma M, Adel S et al. GREAT Network. 2-Day versus C-reactive protein guided antibiotic therapy with levofloxacin in acute COPD exacerbation: A randomized controlled trial. PLoS One 2021; 16: e0251716

  26. Austin MA, Wills KE, Blizzard L et al. Effect of high flow oxygen on mortality in chronic obstructive pulmonary disease patients in prehospital setting: randomised controlled trial. BMJ 2010; 341: c5462

  27. Gottlieb J, Capetian P, Hamsen U et al. S3-Leitlinie: Sauerstoff in der Akuttherapie beim Erwachsenen. Langversion 1.0 - Juni 2021. AWMF-Registernummer: 020 - 021

  28. Westhoff M, Schönhofer B, Neumann P et al. Nicht-invasive Beatmung als Therapie der akuten respiratorischen Insuffizienz. S3-Leitlinie herausgegeben von der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e.V. Pneumologie 2015; 69: 719-56

  29. Tillie-Leblond I, Marquette CH, Perez T et al. Pulmonary embolism in patients with unexplained exacerbation of chronic obstructive pulmonary disease: prevalence and risk factors. Ann Intern Med 2006; 144: 390-6

  30. Han W, Wang M, Xie Y et al. Prevalence of Pulmonary Embolism and Deep Venous Thromboembolism in Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis. Front Cardiovasc Med 2022; 9: 732855

  31. Hassen MF, Tilouche N, Jaoued O et al. Incidence and Impact of Pulmonary Embolism During Severe COPD Exacerbation. Respir Care 2019; 64: 1531-6

  32. Albert RK, Connett J, Bailey WC et al. COPD Clinical Research Network. Azithromycin for prevention of exacerbations of COPD. N Engl J Med 2011; 365: 689-98

  33. Janjua S, Mathioudakis AG, Fortescue R et al. Prophylactic antibiotics for adults with chronic obstructive pulmonary disease: a network meta-analysis. Cochrane Database Syst Rev 2021; 1: CD013198

  34. Ahmadian S, Sin DD, Lynd L et al. Benefit-harm analysis of azithromycin for the prevention of acute exacerbations of chronic obstructive pulmonary disease. Thorax 2022; 77: 1079-87

  35. Trappenburg JCA Monninkhof EM, Bourbeau J et al. Effect of an action plan with ongoing support by a case manager on exacerbation-related outcome in patients with COPD: a multicentre randomised controlled trial. Thorax 2011; 66: 977-84

Download references

Author information

Authors and Affiliations

  1. Klinik für Pneumologie, Schlaf- und Beatmungsmedizin, Lungenklinik Hemer, Theo-Funccius-Str. 1, 58675, Hemer, Deutschland

    Michael Westhoff

Authors
  1. Michael Westhoff
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michael Westhoff.

Ethics declarations

Der Autor erklärt, dass er sich bei der Erstellung des Beitrages von keinen wirtschaftlichen Interessen leiten ließ. Er legt folgende potenzielle Interessenkonflikte offen: keine.

Der Verlag erklärt, dass die inhaltliche Qualität des Beitrags durch zwei unabhängige Gutachten bestätigt wurde. Werbung in dieser Zeitschriftenausgabe hat keinen Bezug zur CME-Fortbildung.

Der Verlag garantiert, dass die CME-Fortbildung sowie die CME-Fragen frei sind von werblichen Aussagen und keinerlei Produktempfehlungen enthalten. Dies gilt insbesondere für Präparate, die zur Therapie des dargestellten Krankheitsbildes geeignet sind.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Westhoff, M. Exazerbation der chronisch obstruktiven Lungenerkrankung. MMW - Fortschritte der Medizin 165, 56–64 (2023). https://doi.org/10.1007/s15006-022-2243-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15006-022-2243-7

Keywords:

Search

Navigation